Dacogen -Decitabine- for Injection Data Presented at American Society of Hematology -ASH- Annual Meeting.
Business Wire › December 06, 2004
Linked as:
Extract
Dacogen -Decitabine- for Injection Data Presented at American Society of Hematology -ASH- Annual Meeting.
SAN DIEGO -- MGI PHARMA, INC. (Nasdaq:MOGN):
-- Final Phase 3 data in MDS presented -- Activity in other hematologic cancers reported MGI PHARMA, INC. (Nasdaq:MOGN) and SuperGen, Inc. (Nasdaq:SUPG) today provided a summary of the Dacogen(TM) (decitabine) for Injection presentations made during the American Society of Hematology (ASH) 46th Annual Meeting and Exposition. Dacogen injection was the subject of four oral presentations, five poster presentations, and two published abstracts at the meeting. Final results of a Phase 3 study of Dacogen injection in patients with myelodysplastic syn...See the full content of this document
Sponsored links
